Gastroenterology Advisor12h
Tirzepatide, Semaglutide Not Cost-Effective at Current Prices
According to a recent study, tirzepatide and semaglutide offer long-term health benefits but are not cost-effective.
Weekly Recap: 14 Health Press Releases You Need to See
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
Weight loss drug Mounjaro launched in India: Know price, how it works, side-effects, and if it’s more effective than Ozempic
The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...
Mounjaro hits shelves in India: How Eli Lilly’s weight loss drug compares with Ozempic — price, side effects and more
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...